Analysts Expect Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) To Breakeven Soon
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Has Found A Path To Profitability
Piper Sandler Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $55
Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024
Form 144 | Agios Pharmaceuticals(AGIO.US) Officer Proposes to Sell 162.46K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Agios Pharmaceuticals(AGIO.US)$ Officer Gheuens Sarah intends to sell 3,705 shares of its common stock on Jul 1, with a total market value of approximately $162.46K.
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
